RESCEU
Respiratory syncytial virus consortium in Europe
- Started
- 2017-01-01
- Website
- http://resc-eu.org/
Respiratory syncytial virus consortium in Europe
Progress novel assets (one FIH start) for non-tubercular mycobacteria that may act synergistically with bedaquiline and cytochrome bc drugs
Progress new assets (one pre-new molecular entity and one first-time-in-human start) for tuberculosis that act synergistically with bedaquiline, cytochrome bc or cytochrome bd inhibitors
Molecular basis of the bacterial cell wall permeability
Boosting Ethionamide efficacy and lowering the dose with a small molecule transcriptional modulators, to overcoming MDR-TB infections and define a new place for Ethionamide in 1st-line TB treatments
Academia and industry united innovation and treatment for tuberculosis
Vaccine lot to vaccine lot comparison by consistency testing
The value of diagnostics to combat antimicrobial resistance by optimising antibiotic use